Valuation: Berkley Renewables Inc.

Market Cap 364K 317K 295K 271K 511K 34.79M 519K 3.48M 1.36M 17.32M 1.37M 1.34M 58.07M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.46M 4.15M 3.81M 7.19M 489M 7.3M 48.89M 19.19M 244M 19.25M 18.83M 817M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 20/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 17/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+1.22%+0.18%+29.88%+2.64% 147B
+0.85%+1.99%+56.32%+65.09% 99.03B
+2.19%+1.57%+27.52%+12.86% 79.2B
+1.59%-0.85%+38.87%+37.24% 57.09B
+2.00%-0.40%+31.47%-8.89% 56.76B
-0.49%+2.35%+106.90%+67.54% 55.57B
+2.17%+0.20%+40.42%-15.93% 52.05B
+0.15%+1.79%+24.20%-13.70% 43.97B
-0.19%+3.28%+55.52%+16.81% 34.97B
Average +0.95%+1.01%+45.68%+18.18% 62.54B
Weighted average by Cap. +1.16%+0.90%+43.49%+19.80%

Financials

2016 2017
Net sales 1.03M 899K 837K 768K 1.45M 98.71M 1.47M 9.86M 3.87M 49.14M 3.88M 3.8M 165M 1.72M 1.5M 1.4M 1.28M 2.42M 165M 2.46M 16.45M 6.46M 81.97M 6.48M 6.34M 275M
Net income 173K 150K 140K 128K 242K 16.49M 246K 1.65M 646K 8.21M 649K 634K 27.52M -631K -548K -510K -468K -885K -60.19M -898K -6.01M -2.36M -29.96M -2.37M -2.32M -100M
Net Debt 2.92M 2.54M 2.36M 2.17M 4.09M 278M 4.16M 27.82M 10.92M 139M 10.96M 10.71M 465M 4.76M 4.14M 3.85M 3.54M 6.68M 455M 6.78M 45.41M 17.82M 226M 17.88M 17.49M 759M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-